$MRVL

Schwab Network on $MRVL (Nov 11, 2026)

AI summary · Schwab Network

MRVL's $115B all-stock Lumentum deal has sound vertical-integration/AI-bottleneck logic, but it adds 50% more shares at a high valuation and the market has heavily discounted it; the speaker believes ~$85B (75 cents per dollar) was wiped out over five or six sessions. The bull case needs AI compute demand to stay strong through 2030; the speaker does not know if it will, and with ~$1B synergies versus the $115B price, unfinished deal math and a >40% fall from the high, he is cautious/neutral-to-positive, watching December 1 earnings for whether excellent profits continue.

He framed it in years
“MRVL Buying LITE for $115B Worth It? Bull Case Hinges on AI Compute Demand”
Schwab NetworkPublished Nov 11 · 18 passages

Playing via YouTube may share device and playback data and use cookies. Privacy Notice · Google Privacy Policy

Jump to any passage

18 passages
0:028:12

Earlier this month, Marvell announced plans to acquire Lumintum in an all-stock deal worth $115 billion . The chip company's offering is just over $1,100 per share, with Marvel shareholders owning about two-thirds of the combined company.

Here's a look at the chart for Marvell, which is currently trading at $169 and some change. We are still a long way from the summer peak we saw in recent months, but we are regaining some of those gains now.

It is interesting to look at the performance since the beginning of the year, as it has risen by about 100%, but it is almost equal to “Lumintom”, which has risen by 82% for 2026.

I do n't think the market is impressed with it at the moment . Regardless of what I think, what we saw was that the deal was worth $115 billion. I believe that over five or six trading sessions, the market wiped out about $85 billion, or 75 cents on every dollar, from Marvell's stock price because of that alone.

If you are attempting a purely balancing deal, i.e., short selling Marvell and buying Lumentum, you are actually getting only about 15% over this 18-month period if the deal goes through .

Am I a buyer for this type of deal? Not exactly, that's not in my risk profile .

Yes, and I think for Marvell...you get an immediate dilution of the number of shares, right? Therefore, 50% of the shares were added, and that was at a very high valuation. Three weeks before the deal was signed, both stocks were at nearly all-time highs.

Could these be peak cycle figures? So I think the question is, with everything that's happening in the field of artificial intelligence, was that deal made at the summit?

Therefore, the markets are a little apprehensive. I think the business logic behind their desire to own Lumintom and everything they are doing in their product line to be more vertically integrated makes sense.

But I think it really comes down to the math and the numbers, and with investors not knowing what that return might look like, it has been heavily discounted now, suggesting that it was at least the right decision in the current environment.

Yes, I think an optimistic outlook is warranted, if you look at the tough numbers on paper, right? The guaranteed synergies amount to approximately $1 billion in cost savings, which is again nothing compared to the $115 billion deal.

But what you're really looking at is if the demand for computing remains strong and cumulative until 2030, then you're looking at that prospect of a $100 billion market, which would then be a great investment.

Therefore, the positive argument is that you are literally buying the bottleneck that represents the obstacle in artificial intelligence and computing power , which will give you the advantage.

This seems logical . I think what we don't know is whether that demand will be met, because the demand for artificial intelligence is insatiable.

This seems similar to what happened when fiber optics were installed, where internet traffic doubled month after month. At some point, that decreases. But what matters, and what the market didn't like despite it being positive for business and fundamentals, is the dilution of the stock by four and a half, and the price of that when the stock reached its highest levels.

Therefore, I think it's a good move from a strategic and vertical integration perspective. But again, these are large numbers. Here I think you should be careful because the transaction calculations may not be completed.

It is interesting to look at Marvel and Lumintom, which have been very close since the beginning of the year so far. But how will you trade this stock, for illustrative purposes, Tom ?

Well, as your guest mentioned, the deal is what confused the stock price at this stage because it is a completely stock deal . Then you look at the retreat. Marvell's stock has fallen by more than 40% from its all-time highs.

So they have profits on December 1st. We will get more clarity regarding their figures. Profits were excellent over the past two quarters. Will this continue at this stage and perhaps provide an upward boost?

So I looked at a two-pronged strategy where you want to sell some of the option premiums because they are currently high. The volatility has widened a little, while at the same time you would be ready to buy shares if the stock's direction reverses and it falls.

So I chose the November 27th weekly course. I will avoid the earnings event but will take advantage of the consolidation here and further upswing or even pullback where you can be wrong and still still be a winner.

For the November 27 weekly options expiring in 16 days, we will sell a cash-covered put option contract , with a neutral to positive outlook here. We will sell a "put" option at an execution price of 148.

It is outside the current price range towards the downside . You will receive an approximate balance of about 310 . It might be slightly less than that. The stock continued to rise.

But the balance you obtain from this type of center is what you can profit from, isn't that right? $310 for each "bot " option you sell. But you have a safety margin towards the breakeven point, which is around 144.90, or about 14.5% less than the current share price.

So you have a large margin of safety towards decline in this type of position. The probability that a put option will expire at an execution price of 148, which is what you want if you wish to keep that balance, is about 77%.

So you have a high probability of success. But remember, if the stock falls below 148, you will have to buy shares. But look at the price you're buying it for. You are buying it at a discount of approximately 14% off its current trading price.

Marvell is up 12% now.

Watchpoints

December 1 earnings report and whether profit growth remains as strong as in the past two quarters

What this channel has said about $MRVL

Schwab Network has 10 calls on this stock; only the adjacent ones are shown.

TickerSays